YURIY EDELEV: Open Payments
NPI 1851827885 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 27 payments from 8 companies in 2025. Trend: 2023 $278 · 2024 $777 · 2025 $1,177
Food & beverage: $1,171Education: $5
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $458 |
| Janssen Pharmaceuticals, Inc | 6 | $209 |
| Otsuka America Pharmaceutical, Inc. | 3 | $177 |
| E.R. Squibb & Sons, L.L.C. | 3 | $162 |
| Alkermes, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, VRAYLAR.
Industry payments across PA — which companies pay providers there.
